Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 21, 2011

Integrated DNA Technologies to Custom Manufacture Quanta Biosciences' miRNA Assays

  • Integrated DNA Technologies (IDT) will custom manufacture assays for quantifying miRNAs developed by Quanta Biosciences under a partnership announced by the companies. IDT, which supplies custom nucleic acids, will produce the assays and supply them directly to Quanta customers through an online catalog.

    Quanta's miRNA products are designed to allow scientists to accurately detect and profile mature miRNA sequences. Early access customers have deployed Quanta's miR assays for toxicology screening during drug development as well as quality control of stem cell pluripotency and differentiation.

    Since 2001, Quanta has been developing and manufacturing life science reagents used for gene-expression profiling, knock-down confirmation, SNP genotyping, biomarker discovery and validation, and array validation. The reagents are used in a variety of industries including pharmaceutical R&D, diagnostics, agriculture, and biodefense.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »